• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰蛋白酶和纤溶酶对血浆激肽释放酶的水解作用及活性片段的形成。

Hydrolysis of plasma kallikrein by trypsin and plasmin and the formation of active fragments.

作者信息

Sampaio C A, Vidmar S, Hamaguchi A, Sampaio M U

出版信息

Adv Exp Med Biol. 1986;198 Pt B:105-11. doi: 10.1007/978-1-4757-0154-8_13.

DOI:10.1007/978-1-4757-0154-8_13
PMID:2949543
Abstract

Active plasma kallikrein (Mr = 90,000) can be separated by reduction of the disulfide bridges into a heavy-chain (Mr = 45,000) and a light-chain (Mr = 36,000). A partially active fragment, corresponding to the light-chain, was isolated during the purification of active human plasma kallikrein. Bovine trypsin can form a fragment corresponding to the heavy-chain when incubated with plasma kallikrein; plasmin also causes the formation of the heavy-chain but at a slower rate. High molecular weight kininogen decreases the rate of cleavage of kallikrein by both enzymes. Light-chain does not accumulate during incubation with these proteases and the heavy-chain, after prolonged incubation is also digested. Incubation of labelled active kallikrein with plasma causes formation of fragments corresponding to the heavy- and the light-chain.

摘要

活性血浆激肽释放酶(分子量=90,000)可通过还原二硫键分离为重链(分子量=45,000)和轻链(分子量=36,000)。在活性人血浆激肽释放酶的纯化过程中,分离出了一个与轻链相对应的部分活性片段。牛胰蛋白酶与血浆激肽释放酶一起孵育时可形成一个与重链相对应的片段;纤溶酶也会导致重链的形成,但速度较慢。高分子量激肽原会降低这两种酶对激肽释放酶的切割速率。与这些蛋白酶孵育时轻链不会积累,长时间孵育后重链也会被消化。用血浆孵育标记的活性激肽释放酶会导致形成与重链和轻链相对应的片段。

相似文献

1
Hydrolysis of plasma kallikrein by trypsin and plasmin and the formation of active fragments.胰蛋白酶和纤溶酶对血浆激肽释放酶的水解作用及活性片段的形成。
Adv Exp Med Biol. 1986;198 Pt B:105-11. doi: 10.1007/978-1-4757-0154-8_13.
2
Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.血浆激肽释放酶和纤溶酶对人高分子量激肽原消化作用的比较。一种改进的高分子量激肽原纯化方法。
J Lab Clin Med. 1987 Apr;109(4):469-79.
3
Isolation and functional properties of the heavy and light chains of human plasma kallikrein.人血浆激肽释放酶重链和轻链的分离及功能特性
J Biol Chem. 1982 Dec 10;257(23):14300-5.
4
Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.血浆激肽释放酶使高分子量激肽原暴露于纤溶酶后,激肽释放增强的机制。
J Lab Clin Med. 1992 Jul;120(1):129-39.
5
Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties.人血浆激肽释放酶重链裂解对其功能特性的影响。
Blood. 1985 Feb;65(2):311-8.
6
Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.人血浆激肽释放酶及其轻链与α2-巨球蛋白的相互作用。
Biochemistry. 1984 Apr 10;23(8):1760-6. doi: 10.1021/bi00303a027.
7
Human inter-alpha-trypsin inhibitor. Limited proteolysis by trypsin, plasmin, kallikrein and granulocytic elastase and inhibitory properties of the cleavage products.人α-间胰蛋白酶抑制剂。胰蛋白酶、纤溶酶、激肽释放酶和粒细胞弹性蛋白酶的有限蛋白水解作用及裂解产物的抑制特性。
Hoppe Seylers Z Physiol Chem. 1979 Sep;360(9):1313-8. doi: 10.1515/bchm2.1979.360.2.1313.
8
Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.人类激肽原的研究。I. 高分子量(HMW)激肽原的分离、特性鉴定及血浆激肽释放酶的裂解作用
J Biochem. 1979 Jan;85(1):249-58. doi: 10.1093/oxfordjournals.jbchem.a132318.
9
High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
Thromb Res. 1979;14(6):817-24. doi: 10.1016/0049-3848(79)90001-x.
10
Isolation of inactive renin from human plasma and its activation by proteolytic enzymes.从人血浆中分离无活性肾素及其被蛋白水解酶激活。
Clin Exp Hypertens A. 1982;4(11-12):2159-67. doi: 10.3109/10641968209062379.